Literature DB >> 2699354

Apomorphine-induced alterations in cortical EEG activity of rats. Involvement of D-1 and D-2 dopamine receptors.

W Kropf1, K Kuschinsky, J Krieglstein.   

Abstract

EEG activity after activation of dopamine receptors of D-1 and/or D-2 type was studied by using telemetric recordings in rats. Apomorphine, a preferential D-2 agonist, produced a characteristic increase in the power of alpha-1 band (7.00-9.50 Hz) when given in doses mediating stereotypies (0.2 or 0.5 mg/kg s.c.). Low doses produced a general increase in the power of all of the bands except beta-2. In particular, delta activity was enhanced which seems to be in correspondence with the sedation observed after these doses (0.02 and 0.05 mg/kg). Haloperidol in a dose which is assumed to block both D-1 and D-2 receptors (0.1 mg/kg i.p.) completely antagonized the alpha-1 activation produced by apomorphine (0.5 mg/kg). A similar, although not complete inhibition of alpha-1 activation was found after administration of a large dose of the selective D-1 antagonist SCH 23390 (0.2 mg/kg i.p.). The selective agonist at D-2 receptors quinpirole (1.0 mg/kg s.c.) produced a less pronounced activation of the power in the alpha-1 band than apomorphine. In general, there was found to be a good correlation between the activation of the alpha-1 activity and stereotyped behaviour. The results suggest that for the full expression of alpha-1 activation, a pronounced activation of D-2 receptors and at least a minimal activation of D-1 receptors, for instance by the endogenous dopamine, is necessary.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2699354     DOI: 10.1007/BF00169680

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  30 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  Excitation-mediating and inhibition-mediating dopamine-receptors: a new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data.

Authors:  A R Cools; J M Van Rossum
Journal:  Psychopharmacologia       Date:  1976-02-02

3.  Effects of apomorphine in quantified electroencephalography in the frontal cortex: changes with dose and time.

Authors:  A Shvaloff; B Tesolin; C Sebban
Journal:  Neuropharmacology       Date:  1988-12       Impact factor: 5.250

Review 4.  Behavioural correlates of the action of selective D-1 dopamine receptor antagonists. Impact of SCH 23390 and SKF 83566, and functionally interactive D-1:D-2 receptor systems.

Authors:  J L Waddington
Journal:  Biochem Pharmacol       Date:  1986-11-01       Impact factor: 5.858

Review 5.  Two dopamine receptors: biochemistry, physiology and pharmacology.

Authors:  J C Stoof; J W Kebabian
Journal:  Life Sci       Date:  1984-12-03       Impact factor: 5.037

6.  The enantiomers of SK&F 83566, a new selective D-1 dopamine antagonist, stereospecifically block stereotyped behaviour induced by apomorphine and by the selective D-2 agonist RU 24213.

Authors:  A G Molloy; J L Waddington
Journal:  Eur J Pharmacol       Date:  1985-10-08       Impact factor: 4.432

7.  Selective dopamine D2 receptor reduction enhances a D1-mediated oral dyskinesia in rats.

Authors:  H Rosengarten; J W Schweitzer; A J Friedhoff
Journal:  Life Sci       Date:  1986-07-07       Impact factor: 5.037

8.  Relationship between amphetamine-induced effects on EEG power spectra and motor activity in rats.

Authors:  G A Young
Journal:  Pharmacol Biochem Behav       Date:  1988-06       Impact factor: 3.533

9.  Sleep induced by low doses of apomorphine in rats.

Authors:  G P Mereu; E Scarnati; E Paglietti; B P Quarantotti; P Chessa; G Di Chiara; G L Gessa
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1979-02

10.  Electrophysiological correlates of stereotyped sniffing in rats injected with apomorphine.

Authors:  C H Vanderwolf; H Szechtman
Journal:  Pharmacol Biochem Behav       Date:  1987-02       Impact factor: 3.533

View more
  8 in total

1.  Conditioning of apomorphine effects: simultaneous analysis of the alterations in cortical electroencephalogram and behaviour.

Authors:  W Kropf; K Kuschinsky; J Krieglstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-06       Impact factor: 3.000

2.  Role of dopamine receptors on electroencephalographic changes produced by repetitive apomorphine treatments in rats.

Authors:  Hwan Soo Jang; Ji Young Kim; Sang Heon Kim; Maan-Gee Lee
Journal:  Korean J Physiol Pharmacol       Date:  2009-06-30       Impact factor: 2.016

3.  Effects of cocaine on the EEG power spectrum of rats are significantly altered after its repeated administration: do they reflect sensitization phenomena?

Authors:  B Ferger; D Stahl; K Kuschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-04       Impact factor: 3.000

4.  Studies on electroencephalogram (EEG) in rats suggest that moderate doses of cocaine or d-amphetamine activate D1 rather than D2 receptors.

Authors:  B Ferger; W Kropf; K Kuschinsky
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

5.  Conditioned effects of apomorphine are manifest in regional EEG of rats both in hippocampus and in striatum.

Authors:  W Kropf; K Kuschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

6.  Discharge profiles of ventral tegmental area GABA neurons during movement, anesthesia, and the sleep-wake cycle.

Authors:  R S Lee; S C Steffensen; S J Henriksen
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

7.  Activation of dopamine D1 receptors or alpha 1 adrenoceptors is not involved in the EEG effect of nicotine in rats.

Authors:  B Ferger; K Kuschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-10       Impact factor: 3.000

8.  Nitric oxide as a mediator of cocaine-induced penile erection in the rat.

Authors:  J Y Chan; C L Huang; S H Chan
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.